These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20627036)

  • 1. [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease].
    Zhu QQ; Lou DJ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ; Li D
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):305-8. PubMed ID: 20627036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China.
    Huang T; Wahlqvist ML; Xu T; Xu A; Zhang A; Li D
    Mol Nutr Food Res; 2010 May; 54 Suppl 1():S112-9. PubMed ID: 19998382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes.
    Shin JY; Kim SK; Lee MY; Kim HS; Ye BI; Shin YG; Baik SK; Chung CH
    Diabetes Res Clin Pract; 2011 Oct; 94(1):156-62. PubMed ID: 21862168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
    Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
    Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
    Zhou WD; Yang YL; Che ZH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.
    Petit JM; Guiu B; Duvillard L; Jooste V; Brindisi MC; Athias A; Bouillet B; Habchi M; Cottet V; Gambert P; Hillon P; Cercueil JP; Verges B
    Clin Nutr; 2012 Aug; 31(4):520-5. PubMed ID: 22209679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasma phospholipid omega-3 polyunsaturated fatty acids and type 2 diabetes is sex dependent: The Hunter Community Study.
    Abbott KA; Burrows TL; Thota RN; Alex A; Acharya S; Attia J; McEvoy M; Garg ML
    Clin Nutr; 2020 Apr; 39(4):1059-1066. PubMed ID: 31023487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.
    Ma YH; Zhao L; Xian XD; Yang D; Huang W; Wang YH; Mueller O; Chang E; Konigshofer Y; Van-Cleve M; Liu G; Yang JK
    Clin Chem Lab Med; 2009; 47(9):1067-72. PubMed ID: 19728847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease.
    Eraslan S; Kizilgul M; Uzunlulu M; Colak Y; Ozturk O; Tuncer I
    Minerva Med; 2013 Aug; 104(4):447-53. PubMed ID: 24008607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
    Hu ZW; Guo JW; Deng XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Associated risk factors of fatty liver in the patients with type 2 diabetes mellitus].
    Chen QK; Chen HY; Wang LY; Zeng ZY; Zhou XD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):414-6. PubMed ID: 15268806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.
    Enjoji M; Kotoh K; Kato M; Higuchi N; Kohjima M; Nakashima M; Nakamuta M
    Int J Mol Med; 2008 Oct; 22(4):521-7. PubMed ID: 18813860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.